Trials / Completed
CompletedNCT03858075
Safety, Tolerability, Pharmacokinetics, and Food Effect of BLU-782 in Healthy Adults
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose and Food Effect Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BLU-782 When Administered Orally to Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 108 (actual)
- Sponsor
- Blueprint Medicines Corporation · Industry
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The main objectives of this study are to assess the safety, tolerability, pharmacokinetics (PK), and food effect of BLU-782 in healthy adult subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BLU-782 | oral capsules |
| DRUG | Placebo | oral capsules |
| DRUG | BLU-782 taken with food | oral capsules |
Timeline
- Start date
- 2019-02-12
- Primary completion
- 2019-09-11
- Completion
- 2019-09-11
- First posted
- 2019-02-28
- Last updated
- 2019-11-08
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03858075. Inclusion in this directory is not an endorsement.